Elos Medtech AB: Elos Medtech Interim Report 1 January - 30 September, 2023
July - September 2023
- Net sales for the third quarter amounted to SEK 251.2 (231.5) million, an increase of 8.5 percent compared to the same quarter last year. Net sales in local currencies increased by 4.3 percent.
- Operating profit amounted to SEK 31.7 (37.7) million, corresponding to an operating margin of 12.6 (16.3) percent.
- Profit after net financial items amounted to SEK 30.9 (29.0) million. Net financial items were positively affected by exchange rate differences of SEK 7.5 (-5.3) million and totaled SEK -0.8 (-8.7) million.
- Cash flow from operating activities was SEK 29.0 (55.3) million, and SEK -25.1 (25.6) million after investments.
- Earnings per share amounted to SEK 2.68 (2.71).